Curable composition, cured film, display panel or OLED light, and method for producing cured product

US11267932B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11267932-B2
Application numberUS-201816047508-A
CountryUS
Kind codeB2
Filing dateJul 27, 2018
Priority dateJul 31, 2017
Publication dateMar 8, 2022
Grant dateMar 8, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A curable composition which is capable of forming a cured product having satisfactory heat resistance and adhesion to a base material, and has satisfactory curability, a cured film obtained from a cured product of the curable composition, a display panel or an OLED light provided with the cured film, and a method for producing a cured product using the curable composition. The composition includes a curable compound and a cationic polymerization initiator, and contains a cationic polymerizable compound having, as the main skeleton, a fused ring in which three or more rings including an aromatic ring are fused, and a salt including a gallium-containing anion as the cationic polymerization initiator.

First claim

Opening claim text (preview).

What is claimed is: 1. A curable composition comprising a curable compound (A) and a cationic polymerization initiator (B), wherein the curable compound (A) comprises a compound represented by the following formula (a1), with the provisos that the compound represented by the formula (a1) does not comprise a vinyl group, and the compound represented by the formula (a1) is not a compound in which one R 3 represents a thiiran-2-ylmethyl group and the other R 3 represents a hydrogen atom or in which each R 3 represents a thiiran-2-ylmethyl group, and the cationic polymerization initiator (B) is a compound comprising a cation moiety and an anion moiety, the anion moiety being an anion represented by the following formula (b1): wherein, in the formula (a1), W 1 and W 2 are each independently a group represented by the following formula (a2): wherein, in the formula (a2), a ring Z represents a fused polycyclic aromatic hydrocarbon ring, X represents a single bond or a group represented by —S—, R 1 represents a single bond, an alkylene group having 1 or more and 4 or less carbon atoms, or an alkyleneoxy group having 1 or more and 4 or less carbon atoms, and when R 1 is an alkyleneoxy group, the oxygen atom in the alkyleneoxy group is bonded with a ring Z, R 2 represents a monovalent hydrocarbon group, a hydroxyl group, a group represented by —OR 4a , a group represented by —SR 4b , an acyl group, an alkoxycarbonyl group, a halogen atom, a nitro group, a cyano group, a mercapto group, a carboxy group, an amino group, a carbamoyl group, a group represented by —NHR 4c , a group represented by —N(R 4d ) 2, a sulfo group, or a group in which at least part of hydrogen atoms bonded to a carbon atom(s) included in a monovalent hydrocarbon group, a group represented by —OR 4a , a group represented by —SR 4b , an acyl group, an alkoxycarbonyl group, a group represented by -NHR 4 c, or a group represented by -N(R 4d ) 2 are substituted with a monovalent hydrocarbon group, a hydroxyl group, a group represented by —OR 4a , a group represented by —SR 4b , an acyl group, an alkoxycarbonyl group, a halogen atom, a nitro group, a cyano group, a mercapto group, a carboxy group, an amino group, a carbamoyl group, a group represented by —NHR 4c , a group represented by —N(R 4d ) 2, a mesyloxy group, or a sulfo group, R 4a to R 4d independently represent a monovalent hydrocarbon group, m represents an integer of 0 or more, and R 3 is a hydrogen atom, a thiiran-2-ylmethyl group, or a glycidyl group, both W 1 and W 2 do not have a hydrogen atom as R 3 , a ring Y 1 and a ring Y 2 represent the same or different aromatic hydrocarbon ring, R represents a single bond, an optionally substituted methylene group, an ethylene group which is optionally substituted and optionally comprises a heteroatom between two carbon atoms, a group represented by —O—, a group represented by —NH—, or a group represented by —S—, R 3a and R 3b independently represent a cyano group, a halogen atom, or a monovalent hydrocarbon group, and n1 and n2 independently represent an integer of 0 or more and 4 or less: wherein, in the formula (b1), R a , R b , R c and R d are each independently an optionally substituted hydrocarbon group, and at least one of R a , R b , R c and R d is an optionally substituted aromatic hydrocarbon group. 2. The curable composition according to claim 1 , further comprising a cationic polymerization initiator (C). 3. The curable composition according to claim 2 , wherein the cationic polymerization initiator (B) and/or the cationic polymerization initiator (C) comprises a sulfonium salt, comprising a cation moiety and an anion moiety, wherein the cation moiety is represented by the following formula (c1): wherein, in the formula (c1), R c1 and R c2 independently represent an alkyl group optionally substituted with a halogen atom, or a group represented by the following formula (c2), R c1 and R c2 are optionally combined with each other to form a ring together with the sulfur atom in the formula, R c3 represents a group represented by the following formula (c3), or a group represented by the following formula (c4), A c1 represents S, O, or Se, provided that R c1 and R c2 are not simultaneously an alkyl group optionally substituted with a halogen atom: wherein, in the formula (c2), a ring Z c1 represents an aromatic hydrocarbon ring, R c4 represents an alkyl group optionally substituted with a halogen atom, a hydroxy group, an alkoxy group, an alkylcarbonyl group, an alkoxycarbonyl group, an acyloxy group, an alkylthio group, a thienyl group, a thienylcarbonyl group, a furanyl group, a furanylcarbonyl group, a selenophenyl group, a selenophenylcarbonyl group, a heterocyclic aliphatic hydrocarbon group, an alkylsulfinyl group, an alkylsulfonyl group, a hydroxy(poly)alkyleneoxy group, an optionally substituted amino group, a cyano group, a nitro group, or a halogen atom, and ml represents an integer of 0 or more: wherein, in the formula (c3), R c5 represents a hydroxy group, an alkoxy group, an alkylcarbonyl group, an arylcarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an arylthiocarbonyl group, an acyloxy group, an arylthio group, an alkylthio group, an aryl group, a heterocyclic hydrocarbon group, an aryloxy group, an alkylsulfinyl group, an arylsulfinyl group, an alkylsulfonyl group, an arylsulfonyl group, a hydroxy(poly)alkyleneoxy group, an optionally substituted amino group, an alkylene group optionally substituted with a cyano group, a nitro group or a halogen atom, or a group represented by the following formula (c5), R c6 represents a hydroxy group, an alkoxy group, an alkylcarbonyl group, an arylcarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an arylthiocarbonyl group, an acyloxy group, an arylthio group, an alkylthio group, an aryl group, a heterocyclic hydrocarbon group, an aryloxy group, an alkylsulfinyl group, an arylsulfinyl group, an alkylsulfonyl group, an arylsulfonyl group, a hydroxy(poly)alkyleneoxy group, an optionally substituted amino group, an alkyl group optionally substituted with a cyano group, a nitro group or a halogen atom, or a group represented by the following formula (c6), A c2 represents a single bond, S, O, a sulfinyl group, or a carbonyl group, and m2 represents 0 or 1: wherein, in the formula (c4), R c7 and R c8 independently represent a hydroxy group, an alkoxy group, an alkylcarbonyl group, an arylcarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an arylthiocarbonyl group, an acyloxy group, an arylthio group, an alkylthio group, an aryl group, a heterocyclic hydrocarbon group, an aryloxy group, an alkylsulfinyl group, an arylsulfinyl group, an alkylsulfonyl group, an arylsulfonyl group, a hydroxy(poly)alkyleneoxy group, an optionally substituted amino group, an alkylene group optionally substituted with a cyano group, a nitro group or a halogen atom, or a group represented by the following formula (c5), R c9 and R c10 independently represent an alkyl group optionally substituted with a halogen atom, or a group represente

Assignees

Inventors

Classifications

  • C08G59/245Primary

    aromatic · CPC title

  • in the presence of solvent vapors, e.g. solvent vapour annealing · CPC title

  • using coherent electromagnetic radiation, e.g. laser annealing · CPC title

  • Encapsulations · CPC title

  • Active-matrix OLED [AMOLED] displays · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11267932B2 cover?
A curable composition which is capable of forming a cured product having satisfactory heat resistance and adhesion to a base material, and has satisfactory curability, a cured film obtained from a cured product of the curable composition, a display panel or an OLED light provided with the cured film, and a method for producing a cured product using the curable composition. The composition inclu…
Who is the assignee on this patent?
Tokyo Ohka Kogyo Co Ltd
What technology area does this patent fall under?
Primary CPC classification C08G59/245. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).